![](/img/cover-not-exists.png)
Sixteen years follow-up results of a randomized phase II trial of neoadjuvant fluorouracil, doxorubicin, and cyclophosphamide (FAC) compared with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in stage III breast cancer: GOCS experience
Leone, José Pablo, Leone, Julieta, Vallejo, Carlos Teodoro, Pérez, Juan Eduardo, Romero, Alberto Omar, Machiavelli, Mario Raul, Romero Acuña, Luis, DomÃnguez, MarÃa Ester, Langui, Mario, Fasce, HVolume:
143
Language:
english
Journal:
Breast Cancer Research and Treatment
DOI:
10.1007/s10549-013-2806-5
Date:
January, 2014
File:
PDF, 359 KB
english, 2014